A detailed history of Community Bank, N.A. transactions in Regulus Therapeutics Inc. stock. As of the latest transaction made, Community Bank, N.A. holds 690 shares of RGLS stock, worth $1,173. This represents 0.0% of its overall portfolio holdings.

Number of Shares
690
Previous 690 -0.0%
Holding current value
$1,173
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$1.27 - $1.76 $876 - $1,214
690 New
690 $0
Q2 2022

Jul 26, 2022

BUY
$1.6 - $3.4 $1,104 - $2,346
690 New
690 $1,000

Others Institutions Holding RGLS

About Regulus Therapeutics Inc.


  • Ticker RGLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,634,400
  • Market Cap $24.9M
  • Description
  • Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-thre...
More about RGLS
Track This Portfolio

Track Community Bank, N.A. Portfolio

Follow Community Bank, N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Community Bank, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Community Bank, N.A. with notifications on news.